Accessibility Menu
 

Clorox (CLX) Q4 EPS Jumps 58%

By Motley Fool Markets Team Aug 2, 2025 at 4:44AM EST

Key Points

  • Clorox delivered a substantial beat on both revenue (GAAP) and adjusted EPS (non-GAAP) in Q4 FY2025, primarily due to a one-time boost from ERP-related shipments.
  • Underlying consumer demand and organic growth trends were soft, with core sales remaining flat when excluding the non-recurring shipment impact.
  • Management forecasted a 6% to 10% sales decline and an 18% to 23% drop in adjusted EPS for FY2026, as temporary benefits reverse and cost pressures increase.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.